×
Entrez Id:
3159
Gene Symbol:
HMGA1
HMGA1
0.510
Biomarker
group
MGD
×
Entrez Id:
2313
Gene Symbol:
FLI1
FLI1
0.100
Biomarker
group
HPO
×
Entrez Id:
6778
Gene Symbol:
STAT6
STAT6
0.100
Biomarker
group
HPO
×
Entrez Id:
5573
Gene Symbol:
PRKAR1A
PRKAR1A
0.100
Biomarker
group
HPO
×
Entrez Id:
6794
Gene Symbol:
STK11
STK11
0.100
Biomarker
group
HPO
×
Entrez Id:
6794
Gene Symbol:
STK11
STK11
0.100
CausalMutation
group
CLINVAR
×
Entrez Id:
5728
Gene Symbol:
PTEN
PTEN
0.100
Biomarker
group
HPO
×
Entrez Id:
64218
Gene Symbol:
SEMA4A
SEMA4A
0.100
Biomarker
group
HPO
×
Entrez Id:
4665
Gene Symbol:
NAB2
NAB2
0.100
Biomarker
group
HPO
×
Entrez Id:
6224
Gene Symbol:
RPS20
RPS20
0.100
Biomarker
group
HPO
×
Entrez Id:
657
Gene Symbol:
BMPR1A
BMPR1A
0.100
Biomarker
group
HPO
×
Entrez Id:
2099
Gene Symbol:
ESR1
ESR1
0.010
GeneticVariation
group
BEFREE
There does not appear to be any association between the presence or absence of spliced variants of estrogen receptor and uterine tumor formation at the mRNA level.
8735603
1996
×
Entrez Id:
1440
Gene Symbol:
CSF3
CSF3
0.300
Therapeutic
group
CTD_human
Phase II trial of paclitaxel in patients with soft-tissue sarcoma.
9774950
1998
×
Entrez Id:
3757
Gene Symbol:
KCNH2
KCNH2
0.010
Biomarker
group
LHGDN
Selective expression of HERG and Kv2 channels influences proliferation of uterine cancer cells.
15202000
2004
×
Entrez Id:
2925
Gene Symbol:
GRPR
GRPR
0.010
AlteredExpression
group
LHGDN
Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments.
15941862
2005
×
Entrez Id:
1027
Gene Symbol:
CDKN1B
CDKN1B
0.300
Biomarker
group
CTD_human
A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.
16391232
2006
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
0.300
Biomarker
group
CTD_human
K-ras mutations in lung tumors and tumors from other organs are consistent with a common mechanism of ethylene oxide tumorigenesis in the B6C3F1 mouse.
17325976
2007
×
Entrez Id:
140690
Gene Symbol:
CTCFL
CTCFL
0.010
AlteredExpression
group
LHGDN
Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression.
17363524
2007
×
Entrez Id:
3159
Gene Symbol:
HMGA1
HMGA1
0.510
AlteredExpression
group
BEFREE
To determine whether these findings are relevant to human disease, we evaluated primary human uterine neoplasms and found that HMGA1a mRNA and protein levels are increased in most high-grade neoplasms but not in normal uterine tissue, benign tumors, or most low-grade neoplasms.
17483309
2007
×
Entrez Id:
1956
Gene Symbol:
EGFR
EGFR
0.020
AlteredExpression
group
BEFREE
Concomitant erbB-1 and erbB-2 overexpression was detected only in 1 out of 25 (4%) uterine neoplasms . erbB-1 was overexpressed in a sarcoma botryoides of the uterine cervix.
17549377
2007
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
0.010
AlteredExpression
group
BEFREE
Concomitant erbB-1 and erbB-2 overexpression was detected only in 1 out of 25 (4%) uterine neoplasms . erbB-1 was overexpressed in a sarcoma botryoides of the uterine cervix.
17549377
2007
×
Entrez Id:
6790
Gene Symbol:
AURKA
AURKA
0.010
GeneticVariation
group
LHGDN
STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot study.
17599395
2007
×
Entrez Id:
1956
Gene Symbol:
EGFR
EGFR
0.020
Biomarker
group
LHGDN
MMTV-EGF receptor transgene promotes preneoplastic conversion of multiple steroid hormone-responsive tissues.
17960555
2008
×
Entrez Id:
331
Gene Symbol:
XIAP
XIAP
0.010
Biomarker
group
LHGDN
Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol.
18071906
2008
×
Entrez Id:
207
Gene Symbol:
AKT1
AKT1
0.010
Biomarker
group
LHGDN
Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol.
18071906
2008